A trial to see if 5-ALA can help to confirm the grade of a brain tumour during surgery (GALA-BIDD)

Overview

Cancer types:

Brain (and spinal cord) tumours

Status:

Results

Phase:

Other

Details

This trial looked at a drug called 5-aminolevulinic acid (5-ALA) to see if it could help surgeons confirm the of a brain tumour during surgery. 5-ALA is also called Gliolan.

This trial was for people with a type of brain tumour called a glioma.

It was supported by Cancer Research UK. People could join the trial between 2015 and 2017. The team published the results in 2023.

Recruitment start: 28 February 2015

Recruitment end: 8 March 2017

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Colin Watts

Supported by

Cambridge University Hospitals NHS Foundation Trust

Cancer Research UK

NIHR Clinical Research Network: Cancer

University of Cambridge

NIHR Cambridge Biomedical Research Centre

Last reviewed: 09 Jun 2026

CRUK internal database number: 12588

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Find a Clinical Trial

Search our clinical trials database for all cancer trials and studies recruiting in the UK.

An icon of two speech bubbles, indicating a conversation.

Cancer Chat forum

Connect with other people affected by cancer and share your experiences.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.